ISPC Stock Analysis: Buy, Sell, or Hold?
ISPC - iSpecimen Inc. Common Stock
$0.14
-0.01 (-6.96%)
▼
5d:
-10.49%
30d:
-44.61%
90d:
-45.63%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Apr 13, 2026
10d
Get Alerted When ISPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ISPC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ISPC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ISPC is currently trading at $0.14, which is considered oversold relative to its 30-day fair value range of $0.17 to $0.26.
Technical Outlook: Technically, ISPC is in a strong downtrend. The price is currently testing key support at $0.14. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: ISPC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.00 (+1873.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ISPC is in a strong downtrend. The price is currently testing key support at $0.14. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: ISPC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.00 (+1873.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.17 -
$0.26
Company Quality Score
46/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-7.0%)
- BULLISH: Trading 1873.7% below Wall St target ($3.00)
- CAUTION: 5-day price weakness (-10.5%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.17 -
$0.26
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.14
Resistance Level
$0.21
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Wall Street Target
$3.00
(+1873.7%)
Revenue Growth (YoY)
-96.0%
Share & Embed Analysis
Last updated: April 02, 2026 12:46 PM ET
Data refreshes hourly during market hours. Next update: 1:46 PM
Data refreshes hourly during market hours. Next update: 1:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ISPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 66 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 62 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 66 BUY |
